The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cells

• Kanagaraju Ponnusamy,
• Linping Chen-Wichmann,
• Olga N. Kuvardina,
• Jörn Lausen,
• Reinhard Henschler,
• Christian Wichmann

Affiliations

Kanagaraju Ponnusamy

Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich;;Institute of Transfusion Medicine and Immunohematology, Goethe University, Frankfurt; and

Linping Chen-Wichmann

Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich;;Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany

Olga N. Kuvardina

Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany

Jörn Lausen

Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany

Reinhard Henschler

Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich;;Institute of Transfusion Medicine and Immunohematology, Goethe University, Frankfurt; and

Christian Wichmann

Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich;;Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany